33 results on '"Wisniowska, Barbara"'
Search Results
2. 3D printing combined with biopredictive dissolution and PBPK/PD modeling optimization and personalization of pharmacotherapy: Are we there yet?
3. Physiologically based modelling of dermal absorption and kinetics of consumer-relevant chemicals: A case study with exposure to bisphenol A from thermal paper
4. Better prediction of the local concentration–effect relationship: the role of physiologically based pharmacokinetics and quantitative systems pharmacology and toxicology in the evolution of model-informed drug discovery and development
5. Thorough QT (TQT) studies: concordance with torsadogenesis and an evolving cardiac safety testing paradigm
6. Am I or am I not proarrhythmic? Comparison of various classifications of drug TdP propensity
7. Virtual Clinical Trial Toward Polytherapy Safety Assessment: Combination of Physiologically Based Pharmacokinetic/Pharmacodynamic-Based Modeling and Simulation Approach With Drug-Drug Interactions Involving Terfenadine as an Example
8. Prediction of the hERG Potassium Channel Inhibition Potential with Use of the Artificial Neural Networks
9. In vitro–in vivo extrapolation of drug-induced proarrhythmia predictions at the population level
10. Virtual Thorough QT (TQT) Trial—Extrapolation of In Vitro Cardiac Safety Data to In Vivo Situation Using Multi-Scale Physiologically Based Ventricular Cell-wall Model Exemplified with Tolterodine and Fesoterodine
11. Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin
12. Prediction of the hERG potassium channel inhibition potential with use of artificial neural networks
13. The database for in silico cardiac risk prediction tools
14. Data on ADME parameters of bisphenol A and its metabolites for use in physiologically based pharmacokinetic modelling
15. BDTcomparator: a program for comparing binary classifiers
16. Quantitative Assessment of the Physiological Parameters Influencing QT Interval Response to Medication - Simulation Study
17. Various Mathematical Models Towards Assessment of the Cardiac Consequences of Drug Combinations and Multiple-currents Inhibition: In Silico Study to Predict In Vivo Effects
18. Comparison of Proarrhythymia Classification Models
19. Effect of multiple drugs interacting with the hERG channel—In vitro study
20. Population level simulation of the action potential as a system for the drugs proarrhythmic potency classification
21. Systems Pharmacology based approach utilized for prediction of the cardiac consequences of drug–drug interactions
22. To sum or not to sum: How to assess torsadogenic potential of combination of drugs and their active metabolites—In vitro assessment with loratadine and desloratadine as the exemplary drugs
23. Tox-Database.net—Knowledge for drug development
24. Electrophysiologically inactive drugs – Can we predict their cardiotoxicity?
25. Virtual population generator for human cardiomyocytes parameters:in silicodrug cardiotoxicity assessment
26. The open-access dataset for insilico cardiotoxicity prediction system
27. hERG channel trafficking mutations — Their role in the drug triggered arrhythmia — Simulation study
28. In silico prediction of the drug overdose consequences at the heart electrophysiology level.
29. ToxComp ∔ In vitro-in vivo extrapolation system for drug proarrhythmic potency assessment.
30. Modeling and simulation approach for assessing proarrhythmic potency of the non-cardiological drugs.
31. Empirical modeling of the sodium channel inhibition caused by drugs.
32. Computer-based prediction of the drug proarrhythmic effect: problems, issues, known and suspected challenges.
33. Virtual population generator for human cardiomyocytes parameters: in silico drug cardiotoxicity assessment.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.